KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding
Others
Ratios

AbCellera Biologics (ABCL) Non Operating Income (2020 - 2023)

Historic Non Operating Income for AbCellera Biologics (ABCL) over the last 4 years, with Q4 2023 value amounting to $17.5 million.

  • AbCellera Biologics' Non Operating Income rose 17412.82% to $17.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $63.2 million, marking a year-over-year increase of 17970.07%. This contributed to the annual value of $114.4 million for FY2024, which is 8102.98% up from last year.
  • AbCellera Biologics' Non Operating Income amounted to $17.5 million in Q4 2023, which was up 17412.82% from $15.6 million recorded in Q3 2023.
  • In the past 5 years, AbCellera Biologics' Non Operating Income ranged from a high of $17.5 million in Q4 2023 and a low of -$13.5 million during Q4 2020
  • Over the past 4 years, AbCellera Biologics' median Non Operating Income value was $5.4 million (recorded in 2021), while the average stood at $5.7 million.
  • In the last 5 years, AbCellera Biologics' Non Operating Income plummeted by 6955.65% in 2022 and then surged by 78642.38% in 2023.
  • AbCellera Biologics' Non Operating Income (Quarter) stood at -$13.5 million in 2020, then skyrocketed by 123.43% to $3.2 million in 2021, then skyrocketed by 101.65% to $6.4 million in 2022, then soared by 174.13% to $17.5 million in 2023.
  • Its Non Operating Income stands at $17.5 million for Q4 2023, versus $15.6 million for Q3 2023 and $13.4 million for Q2 2023.